News for STAAR Surgical Company (STAA)

Staar Surgical (NASDAQ:STAA) announced the following leadership changes: Warren Foust has been promoted to the newly created role of President and Chief Operating Officer. Magda Michna has been elevated to the newly created role

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLâ„¢) for vision correction

PR NewswireNEW YORK, March 17, 2025 NEW YORK, March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical

U.S. stocks were lower, with the Nasdaq Composite falling around 650 points on Monday. Shares of Redfin Corporation RDFN rose sharply during Monday's session a...

PR NewswireNEW YORK, March 3, 2025 NEW YORK, March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical C

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLâ„¢) for vision correction

PR NewswireNEW YORK, Feb. 25, 2025 NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical

PR NewswireLOS ANGELES, Feb. 18, 2025 LOS ANGELES, Feb. 18, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announ

PR NewswireNEW YORK, Feb. 18, 2025 NEW YORK, Feb. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of STAAR Surgical

Operator: Greetings and welcome to the STAAR Surgical Fourth Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today Tuesday, February 11th, 2025.

PR NewswireLOS ANGELES, Feb. 13, 2025 LOS ANGELES, Feb. 13, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announ

STAAR Surgical Company (NASDAQ:STAA) Q4 2024 Earnings Call Transcript February 11, 2025 5:00 PM ETCompany ParticipantsBrian Moore - VP, Investor Relations...

The following slide deck was published by STAAR Surgical Company in conjunction with their 2024 Q4 earnings call.

[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of STAAR Surg

Stock Market Today saw a sharp decline as the Dow Jones plummeted 400 points following a rise in US Inflation to 3% YoY. The latest CPI data released by the US Bureau of Labor Statistics dampened investor hopes for Federal Reserve rate cuts. The S&P 500 and Nasdaq Composite also opened lower, reflecting market uncertainty. Key stocks like Microsoft, Amazon, and Nike took a hit, while Apple and JPMorgan managed gains. With inflation higher than expected, the Feds stance on interest rates remains firm, adding to market volatility. Investors are closely watching for future economic cues.

Mizuho has downgraded STAAR Surgical (STAA) to neutral from outperform, citing a slowdown in sales of its Implantable Collamer Lenses, or ICLs,  in China. Read more here.

STAAR Surgical's Q4 results were severely impacted by lower demand and high inventory levels in China. Check out why I maintain my buy rating on STAA stock.

Virginia-based Spire Global, Inc. (SPIR) is down over 52 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Wednesday. Shares of Teradata Corporation TDC fell sharply in toda...